Tay’s License Agreement with VYNE Therapeutics

Pietro Martinoia
Tagged:

Goodwin advised Tay on the agreement.Tay entered into a license agreement with VYNE Therapeutics, under which VYNE obtained exclusive rights to Tay’s oral BET inhibitor, TAY-B2 (VYN202)….

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now